NasdaqGS:CERTHealthcare Services
Is Certara (CERT) A Bargain Following Its NVIDIA AI Collaboration?
Certara (CERT) is back in focus after announcing a collaboration with NVIDIA to bring the BioNeMo Agent Toolkit into its open integrated AI platform for drug development and biosimulation clients.
See our latest analysis for Certara.
Certara's latest AI collaboration comes after a sharp 30 day share price return of 25.27%, although the year to date share price return is down 20.59% and the 1 year total shareholder return has fallen 31.56%. This points to improving short term momentum against...